By Associate Professor Suzanne Jean Hodgkinson

Journal articles

Verma ND; Lam AD; Chiu C; Tran GT; Hall BM; Hodgkinson SJ, 2021, 'Multiple sclerosis patients have reduced resting and increased activated CD4+CD25+FOXP3+T regulatory cells', Scientific Reports, 11, pp. 10476, http://dx.doi.org/10.1038/s41598-021-88448-5

Hall BM; Hall RM; Tran GT; Robinson CM; Wilcox PL; Rakesh PK; Wang C; Sharland AF; Verma ND; Hodgkinson SJ, 2021, 'Interleukin-5 (IL-5) Therapy Prevents Allograft Rejection by Promoting CD4+CD25+ Ts2 Regulatory Cells That Are Antigen-Specific and Express IL-5 Receptor', Frontiers in Immunology, 12, pp. 714838, http://dx.doi.org/10.3389/fimmu.2021.714838

Maltby VE; Lea RA; Monif M; Fabis-Pedrini MJ; Buzzard K; Kalincik T; Kermode AG; Taylor B; Hodgkinson S; McCombe P; Butzkueven H; Barnett M; Lechner-Scott J, 2021, 'Efficacy of Cladribine Tablets as a Treatment for People with Multiple Sclerosis: Protocol for the CLOBAS Study (Cladribine, a Multicenter, Long-Term Efficacy and Biomarker Australian Study)', Jmir Research Protocols, 10, http://dx.doi.org/10.2196/24969

Clarke L; Arnett S; Bukhari W; Khalilidehkordi E; Jimenez Sanchez S; O'Gorman C; Sun J; Prain KM; Woodhall M; Silvestrini R; Bundell CS; Abernethy DA; Bhuta S; Blum S; Boggild M; Boundy K; Brew BJ; Brownlee W; Butzkueven H; Carroll WM; Chen C; Coulthard A; Dale RC; Das C; Fabis-Pedrini MJ; Gillis D; Hawke S; Heard R; Henderson APD; Heshmat S; Hodgkinson S; Kilpatrick TJ; King J; Kneebone C; Kornberg AJ; Lechner-Scott J; Lin MW; Lynch C; Macdonell RAL; Mason DF; McCombe PA; Pereira J; Pollard JD; Ramanathan S; Reddel SW; Shaw CP; Spies JM; Stankovich J; Sutton I; Vucic S; Walsh M; Wong RC; Yiu EM; Barnett MH; Kermode AGK; Marriott MP; Parratt JDE; Slee M; Taylor BV; Willoughby E; Brilot F; Vincent A; Waters P; Broadley SA, 2021, 'MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis', Frontiers in Neurology, 12, http://dx.doi.org/10.3389/fneur.2021.722237

Yeh WZ; Widyastuti PA; Van der Walt A; Stankovich J; Havrdova E; Horakova D; Vodehnalova K; Ozakbas S; Eichau S; Duquette P; Kalincik T; Patti F; Boz C; Terzi M; Yamout BI; Lechner-Scott J; Sola P; Skibina OG; Barnett M; Onofrj M; Sá MJ; McCombe PA; Grammond P; Ampapa R; Grand'Maison F; Bergamaschi R; Spitaleri DLA; Van Pesch V; Cartechini E; Hodgkinson S; Soysal A; Saiz A; Gresle M; Uher T; Maimone D; Turkoglu R; Hupperts RMM; Amato MP; Granella F; Oreja-Guevara C; Altintas A; Macdonell RA; Castillo-Trivino T; Butzkueven H; Alroughani R; Jokubaitis VG, 2021, 'Natalizumab, Fingolimod, and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple Sclerosis', Neurology, 96, pp. E2989 - E3002, http://dx.doi.org/10.1212/WNL.0000000000012084

Vitkova M; Diouf I; Malpas C; Horakova D; Havrdova EK; Patti F; Ozakbas S; Ayuso GI; Madueño SE; Shaygannejad V; Onofrj M; Lugaresi A; Alroughani R; Prat A; Larochelle C; Girard M; Duquette P; Terzi M; Boz C; Grand’Maison F; Sola P; Ferraro D; Grammond P; Butzkueven H; Buzzard K; Skibina O; Yamout B; Karabudak R; Gerlach OHH; Lechner-Scott J; Maimone D; Bergamaschi R; Van Pesch V; Iuliano G; Cartechini E; Sá MJ; Ampapa R; Barnett M; Hughes S; Ramo-Tello C; Hodgkinson S; Spitareli D; Petersen T; Butler E; Slee M; McGuigan C; McCombe P; Granella F; Cristiano E; Prevost J; Taylor B; Sanchez-Menoyo JL; Laureys G; Van Hijfte L; Vucic S; Macdonell R; Gray O; Urtaza FJO; Deri N; Fragoso Y; Shaw C; Kalincik T, 2021, 'Association of Latitude and Exposure to Ultraviolet B Radiation with Severity of Multiple Sclerosis (2554)', Neurology, 96, http://dx.doi.org/10.1212/wnl.96.15_supplement.2554

Wiendl H; Schmierer K; Hodgkinson S; Derfuss T; Chan A; Sellebjerg F; Achiron A; Montalban X; Prat A; De Stefano N; Barkhof F; Leocani L; Vermersch P; Chudecka A; Roy S; Boschert U, 2021, 'Characterization of Peripheral Immune Cell Dynamics and Repopulation Patterns in the First 12 Months of Cladribine Tablets Treatment: MAGNIFY-MS Study (2235)', Neurology, 96, http://dx.doi.org/10.1212/wnl.96.15_supplement.2235

Harding-Forrester S; Roos I; Sharmin S; Diouf I; Malpas C; Nguyen A-L; Moradi N; Horáková D; Havrdová EK; Patti F; Ayuso GI; Madueño SE; Prat A; Girard M; Duquette P; Onofrj M; Lugaresi A; Grand’Maison F; Weinstock-Guttman B; Amato MP; Grammond P; Gerlach O; Ozakbas S; Sola P; Ferraro D; Butzkueven H; Lechner-Scott J; Boz C; Alroughani R; Van Pesch V; Cartechini E; Terzi M; Maimone D; Ramo-Tello C; Spitaleri DLA; Kappos L; Yamout B; Sá MJ; Slee M; Morgado YB; Bergamaschi R; Butler E; Iuliano G; Granella F; Sidhom Y; Gouider R; Ampapa R; Van Wijmeersch B; Karabudak R; Prevost J; Sánchez-Menoyo JL; De Gans K; McCombe P; Castillo-Triviño T; Macdonell R; Altintas A; Laureys G; Van Hijfte L; Van Der Walt A; Vucic S; Türkoǧlu R; Barnett M; Cristiano E; Zakaria M; Shaygannejad V; Hodgkinson S; Soysal A; Buzzard K; Skibina O; Kalincik T, 2021, 'Disability Accrual in Primary Progressive & Secondary Progressive Multiple Sclerosis (2901)', Neurology, 96, http://dx.doi.org/10.1212/wnl.96.15_supplement.2901

Butzkueven H; Spelman T; Hodgkinson S; Kalincik T; Buzzard K; Skabina O; Madueño SE; Ayuso GI; Van der Walt A; Grand-Maison F; Butler E; Prevost J; McCombe P; Oh J; Macdonell R; Lechner-Scott J; Van Pesch V; Duquette P; Prat A; Girard M; Kermode A; Fabris J, 2021, 'Real-world Experience with Cladribine Tablets in the MSBase Registry (2942)', Neurology, 96, http://dx.doi.org/10.1212/wnl.96.15_supplement.2942

De Stefano N; Barkhof F; Montalban X; Achiron A; Derfuss T; Chan A; Hodgkinson S; Prat A; Leocani L; Schmierer K; Sellebjerg F; Vermersch P; Wiendl H; Keller B; Roy S, 2021, 'Reduction in CUA MRI Lesions in the First 6 Months after Cladribine Tablets Treatment for Highly Active Relapsing Multiple Sclerosis: MAGNIFY-MS Subgroup Analysis (1921)', Neurology, 96, http://dx.doi.org/10.1212/wnl.96.15_supplement.1921

Lizak N; Hodgkinson S; Butler E; Lechner-Scott J; Slee M; McCombe PA; Shaw C; Skibina O; Vucic S; Shuey N; Barnett MH; Parratt J; Butzkueven H; Jack D; Fabris J; Kalincik T, 2021, 'Real-world effectiveness of cladribine for Australian patients with multiple sclerosis: An MSBase registry substudy', Multiple Sclerosis Journal, 27, pp. 465 - 474, http://dx.doi.org/10.1177/1352458520921087

Kalincik T; Diouf I; Sharmin S; Malpas C; Spelman T; Horakova D; Havrdova EK; Trojano M; Izquierdo G; Lugaresi A; Prat A; Girard M; Duquette P; Grammond P; Jokubaitis V; Van Der Walt A; Grand'maison F; Sola P; Ferraro D; Shaygannejad V; Alroughani R; Hupperts R; Terzi M; Boz C; Lechner-Scott J; Pucci E; Van Pesch V; Granella F; Bergamaschi R; Spitaleri D; Slee M; Vucic S; Ampapa R; McCombe P; Ramo-Tello C; Prevost J; Olascoaga J; Cristiano E; Barnett M; Saladino ML; Sanchez-Menoyo JL; Hodgkinson S; Rozsa C; Hughes S; Moore F; Shaw C; Butler E; Skibina O; Gray O; Kermode A; Csepany T; Singhal B; Shuey N; Piroska I; Taylor B; Simo M; Sirbu CA; Sas A; Butzkueven H; Iuliano G; Petersen T; Verheul F; Vella N; Kovacs K; Petkovskaboskova T; Erdelyi T; Dobos E; Bolaños RF; Kister I; Cabrera-Gomez JA; Roullet E; Zwanikken C; Den Braber-Moerland L; Der N; Firstenfeld A; Bacile EA; Santiago V; Vrech S C; Hardy T; Arruda WO; Charest S; Oreja-Guevara C; McDonnell G; Rum G; Flechter S; Khurana D; Amato MP; Bojkovski V; Van Munster E; Rio ME; Al-Harbi T; Haartsen J, 2021, 'Effect of Disease-Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years', Neurology, 96, pp. E783 - E797, http://dx.doi.org/10.1212/WNL.0000000000011242

Chan A; Rose J; Alvarez E; Bar-Or A; Butzkueven H; Fox RJ; Gold R; Gudesblatt M; Haartsen J; Spelman T; Wright K; Ferraro D; Sola P; Hodgkinson S; Kalincik T; Lechner-Scott J; McGuigan C; Spach K; Chen C; Fam S; Wu F; Miller C, 2020, 'Lymphocyte reconstitution after DMF discontinuation in clinical trial and real-world patients with MS', Neurology Clinical Practice, 10, pp. 510 - 519, http://dx.doi.org/10.1212/CPJ.0000000000000800

Roos I; Leray E; Frascoli F; Casey R; Brown WJL; Horakova D; Havrdova EK; Trojano M; Patti F; Izquierdo G; Eichau S; Onofrj M; Lugaresi A; Prat A; Girard M; Grammond P; Sola P; Ferraro D; Ozakbas S; Bergamaschi R; Sá MJ; Cartechini E; Boz C; Granella F; Hupperts R; Terzi M; Lechner-Scott J; Spitaleri D; van Pesch V; Soysal A; Olascoaga J; Prevost J; Aguera-Morales E; Slee M; Csepany T; Turkoglu R; Sidhom Y; Gouider R; van Wijmeersch B; McCombe P; Macdonell R; Coles A; Malpas CB; Butzkueven H; Vukusic S; Kalincik T; Duquette P; Grand'Maison F; Iuliano G; Ramo-Tello C; Solaro C; Cabrera-Gomez JA; Rio ME; Bolaños RF; Shaygannejad V; Oreja-Guevara C; Sanchez-Menoyo JL; Petersen T; Altintas A; Barnett M; Flechter S; Fragoso Y; Amato MP; Moore F; Ampapa R; Verheul F; Hodgkinson S; Cristiano E; Yamout B; Laureys G; Dominguez JA; Zwanikken C; Deri N; Dobos E; Vrech C; Butler E; Rozsa C; Petkovska-Boskova T; Karabudak R; Rajda C; Alkhaboori J; Saladino ML; Shaw C; Shuey N; Vucic S; Sempere AP; Campbell J; Piroska I; Taylor B; van der Walt A; Kappos L; Roullet E; Gray O; Simo M; Sirbu CA; Brochet B; Cotton F; de Sèze J; Dion A; Douek P, 2020, 'Delay from treatment start to full effect of immunotherapies for multiple sclerosis', Brain, 143, pp. 2742 - 2756, http://dx.doi.org/10.1093/brain/awaa231

Khalilidehkordi E; Clarke L; Arnett S; Bukhari W; Jimenez Sanchez S; O'Gorman C; Sun J; Prain KM; Woodhall M; Silvestrini R; Bundell CS; Abernethy D; Bhuta S; Blum S; Boggild M; Boundy K; Brew BJ; Brown M; Brownlee W; Butzkueven H; Carroll WM; Chen C; Coulthard A; Dale RC; Das C; Fabis-Pedrini MJ; Fulcher D; Gillis D; Hawke S; Heard R; Henderson APD; Heshmat S; Hodgkinson S; Kilpatrick TJ; King J; Kneebone C; Kornberg AJ; Lechner-Scott J; Lin MW; Lynch C; Macdonell RAL; Mason DF; McCombe PA; Pereira J; Pollard JD; Ramanathan S; Reddel SW; Shaw C; Spies J; Stankovich J; Sutton I; Vucic S; Walsh M; Wong RC; Yiu EM; Barnett MH; Kermode AG; Marriott MP; Parratt J; Slee M; Taylor BV; Willoughby E; Brilot F; Vincent A; Waters P; Broadley SA, 2020, 'Relapse Patterns in NMOSD: Evidence for Earlier Occurrence of Optic Neuritis and Possible Seasonal Variation', Frontiers in Neurology, 11, http://dx.doi.org/10.3389/fneur.2020.00537

Bukhari W; Clarke L; O’Gorman C; Khalilidehkordi E; Arnett S; Prain KM; Woodhall M; Silvestrini R; Bundell CS; Ramanathan S; Abernethy D; Bhuta S; Blum S; Boggild M; Boundy K; Brew BJ; Brownlee W; Butzkueven H; Carroll WM; Chen C; Coulthard A; Dale RC; Das C; Dear K; Fabis-Pedrini MJ; Fulcher D; Gillis D; Hawke S; Heard R; Henderson APD; Heshmat S; Hodgkinson S; Jimenez-Sanchez S; Kilpatrick TJ; King J; Kneebone C; Kornberg AJ; Lechner-Scott J; Lin MW; Lynch C; Macdonnell RAL; Mason DF; McCombe PA; Pereira J; Pollard JD; Reddel SW; Shaw C; Spies J; Stankovich J; Sutton I; Vucic S; Walsh M; Wong RC; Yiu EM; Barnett MH; Kermode AG; Marriott MP; Parratt J; Slee M; Taylor BV; Willoughby E; Wilson RJ; Brilot F; Vincent A; Waters P; Broadley SA, 2020, 'The clinical profile of NMOSD in Australia and New Zealand', Journal of Neurology, 267, pp. 1431 - 1443, http://dx.doi.org/10.1007/s00415-020-09716-4

Tran GT; Hodgkinson SJ; Carter N; Verma ND; Robinson CM; Plain KM; Nomura M; Hall BM, 2020, 'Autoantigen specific IL-2 activated CD4+CD25+T regulatory cells inhibit induction of experimental autoimmune neuritis', Journal of Neuroimmunology, 341, http://dx.doi.org/10.1016/j.jneuroim.2020.577186

Sharmin S; Bovis F; Malpas C; Horakova D; Havrdova E; Ayuso GI; Eichau S; Trojano M; Prat A; Girard M; Duquette P; Onofrj M; Lugaresi A; Grand’Maison F; Grammond P; Sola P; Ferraro D; Terzi M; Hupperts RMM; Alroughani R; Boz C; Shaygannejad V; Van Pesch V; Kappos L; Lechner-Scott J; Bergamaschi R; Turkoglu R; Solaro C; Ramo-Tello C; Iuliano G; Granella F; Van Wijmeersch B; Spitaleri DLA; Bolanos RF; Slee M; McCombe P; Prevost J; Ampapa R; Ozakbas S; Sanchez-Menoyo JL; Soysal A; Vucic OS; Petersen T; Verheul F; Butler E; Hodgkinson S; Sidhom Y; Gouider R; Cristiano E; Urtaza FJO; Saladino ML; Barnett M; Deri N; Moore F; Rozsa C; Yamout B; Skibina O; Gray O; Campbell J; Sempere A; Singhal B; Fragoso Y; Shaw C; Kermode A; Petkovska-Boskova T; Taylor B; Simo M; Vella N; Shuey N; Alkhaboori J; Al-Harbi T; Macdonell R; Dominguez JA; Kister I; Csepany T; Vrech C; Kovacs K; Sirbu CA; Hughes S; Sormani MP; Butzkueven H; Kalincik T, 2020, 'Predicting Long-Term Sustained Disability Progression in Multiple Sclerosis (2002)', Neurology, 94, http://dx.doi.org/10.1212/wnl.94.15_supplement.2002

Butzkueven H; Spelman T; Madueno SE; Grand’Maison F; Kalincik T; Hodgkinson S; Skibina O; Butler E, 2020, 'Real-world experience of oral cladribine use in the MSBase Registry (3942)', Neurology, 94, http://dx.doi.org/10.1212/wnl.94.15_supplement.3942

O’Neill D; Hodgkinson S, 2020, 'Short term efficacy and safety outcomes after switching from Anti-CD20 DMTs to Cladribine in a real-world setting (5389)', Neurology, 94, http://dx.doi.org/10.1212/wnl.94.15_supplement.5389

Fambiatos A; Jokubaitis V; Horakova D; Kubala Havrdova E; Trojano M; Prat A; Girard M; Duquette P; Lugaresi A; Izquierdo G; Grand’Maison F; Grammond P; Sola P; Ferraro D; Alroughani R; Terzi M; Hupperts R; Boz C; Lechner-Scott J; Pucci E; Bergamaschi R; Van Pesch V; Ozakbas S; Granella F; Turkoglu R; Iuliano G; Spitaleri D; McCombe P; Solaro C; Slee M; Ampapa R; Soysal A; Petersen T; Sanchez-Menoyo JL; Verheul F; Prevost J; Sidhom Y; Van Wijmeersch B; Vucic S; Cristiano E; Saladino ML; Deri N; Barnett M; Olascoaga J; Moore F; Skibina O; Gray O; Fragoso Y; Yamout B; Shaw C; Singhal B; Shuey N; Hodgkinson S; Altintas A; Al-Harbi T; Csepany T; Taylor B; Hughes J; Jun JK; van der Walt A; Spelman T; Butzkueven H; Kalincik T, 2020, 'Risk of secondary progressive multiple sclerosis: A longitudinal study', Multiple Sclerosis Journal, 26, pp. 79 - 90, http://dx.doi.org/10.1177/1352458519868990

Lau FS; Mitchelle A; Cheung A; Wenderoth J; Cappelen-Smith C; Cordato D; Hodgkinson S; McDougall A; Zagami AS; Manning NW, 2020, 'Abstract TMP9: Use of Immediate Dual Antiplatelet Therapy in Carotid Stenting for Tandem Occlusion Stroke is Associated With Acceptable Symptomatic Intracranial Haemorrhage Rates', Stroke, 51, http://dx.doi.org/10.1161/str.51.suppl_1.tmp9

McQuinn A; Cheung A; Wenderoth J; Mitchelle A; Blair C; Cappelen-Smith C; Cordato D; Hodgkinson S; McDougall A; Zagami AS; Manning NW, 2020, 'Abstract TP32: Efficacy and Safety of Hyper-acute Stenting for Symptomatic Intracranial Atherosclerotic Disease', Stroke, 51, http://dx.doi.org/10.1161/str.51.suppl_1.tp32

Mitchelle A; Lau FS; Cheung A; Wenderoth J; McQuinn A; Cappelen-Smith C; Cordato D; Hodgkinson S; Blair C; McDougall A; Zagami AS; Manning NW, 2020, 'Abstract WP57: Acute Carotid Stenting Following Intracranial Thrombectomy Has Comparable Safety and Efficacy in Early versus Late Time Window Stroke', Stroke, 51, http://dx.doi.org/10.1161/str.51.suppl_1.wp57

Verma ND; Al-Atiyah R; Tran GT; Hodgkinson SJ; Hall BM, 2020, 'CHANGES IN PHENOTYPE OF HUMAN CD4+CD25+CD127LO TREG SUBPOPULATIONS AFTER CULTURE WITH RIL-2 AND ALLOANTIGEN', Transplantation, 104, pp. S162 - S162, http://dx.doi.org/10.1097/01.tp.0000699152.96447.5a

Rakesh P; Verma ND; Bedi SK; Tran GT; Robinson CM; Hodgkinson SJ; Hall BM, 2020, 'COMPARISON OF TRITIATED THYMIDINE INCORPORATION ASSAY AND AN IN VITRO SUPPRESSION ASSAY OF CD4+CD25-T EFFECTOR CELL PROLIFERATION BY TH2-LIKE TREG AND NAÏVE TREG USING A FLOW CYTOMETRY BASED ASSAY', Transplantation, 104, pp. S162 - S162, http://dx.doi.org/10.1097/01.tp.0000699156.74079.68

Ledingham D; El-Wahsh S; Sebire D; Cappelen-Smith C; Hodgkinson SJ; McDougall AJ; Maley M; Cordato DJ, 2019, 'Adjuvant immunosuppression for paradoxical deterioration in tuberculous meningitis including one case responsive to cyclosporine. A tertiary referral hospital experience', Journal of the Neurological Sciences, 404, pp. 58 - 62, http://dx.doi.org/10.1016/j.jns.2019.07.002

Bhaskar S; Saab J; Cappelen-Smith C; Killingsworth M; Wu XJ; Cheung A; Manning N; Aouad P; McDougall A; Hodgkinson S; Cordato D, 2019, 'Clot Histopathology in Ischemic Stroke with Infective Endocarditis', Canadian Journal of Neurological Sciences, 46, pp. 331 - 336, http://dx.doi.org/10.1017/cjn.2019.8

Bhaskar S; Thomas P; Cheng Q; Clement N; McDougall A; Hodgkinson S; Cordato D, 2019, 'Trends in acute stroke presentations to an emergency department: Implications for specific communities in accessing acute stroke care services', Postgraduate Medical Journal, 95, pp. 258 - 264, http://dx.doi.org/10.1136/postgradmedj-2019-136413

Hodgkinson S; Sharma M, 2019, 'Temporal profile of lymphocytes following treatment with cladribine tablets in patients switching from lymphocyte depleting or sequestering disease modifying drugs (DMDs) (P4.2-034)', Neurology, 92, http://dx.doi.org/10.1212/wnl.92.15_supplement.p4.2-034

Kalincik T; Kubala Havrdova E; Horakova D; Izquierdo G; Prat A; Girard M; Duquette P; Grammond P; Onofrj M; Lugaresi A; Ozakbas S; Kappos L; Kuhle J; Terzi M; Lechner-Scott J; Boz C; Grand'maison F; Prevost J; Sola P; Ferraro D; Granella F; Trojano M; Bergamaschi R; Pucci E; Turkoglu R; McCombe PA; Pesch VV; Van Wijmeersch B; Solaro C; Ramo-Tello C; Slee M; Alroughani R; Yamout B; Shaygannejad V; Spitaleri D; Sánchez-Menoyo JL; Ampapa R; Hodgkinson S; Karabudak R; Butler E; Vucic S; Jokubaitis V; Spelman T; Butzkueven H, 2019, 'Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis', Journal of Neurology Neurosurgery and Psychiatry, 90, pp. 458 - 468, http://dx.doi.org/10.1136/jnnp-2018-319831

Nguyen AL; Havrdova EK; Horakova D; Izquierdo G; Kalincik T; van der Walt A; Terzi M; Alroughani R; Duquette P; Girard M; Prat A; Boz C; Sola P; Ferraro D; Lugaresi A; Lechner-Scott J; Barnett M; Grand'Maison F; Grammond P; Ramo-Tello C; Turkoglu R; McCombe P; Pucci E; Trojano M; Granella F; Spitaleri D; Van Pesch V; Soysal A; Oreja-Guevara C; Verheul F; Vucic S; Hodgkinson S; Slee M; Ampapa R; Prevost J; Menoyo JLS; Skibina O; Solaro C; Olascoaga J; Shaw C; Madsen KG; Naidoo K; Hyde R; Butzkueven H; Jokubaitis V, 2019, 'Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study', Multiple Sclerosis and Related Disorders, 28, pp. 235 - 243, http://dx.doi.org/10.1016/j.msard.2019.01.003

Brown JWL; Coles A; Horakova D; Havrdova E; Izquierdo G; Prat A; Girard M; Duquette P; Trojano M; Lugaresi A; Bergamaschi R; Grammond P; Alroughani R; Hupperts R; McCombe P; Van Pesch V; Sola P; Ferraro D; Grand'Maison F; Terzi M; Lechner-Scott J; Flechter S; Slee M; Shaygannejad V; Pucci E; Granella F; Jokubaitis V; Willis M; Rice C; Scolding N; Wilkins A; Pearson OR; Ziemssen T; Hutchinson M; Harding K; Jones J; McGuigan C; Butzkueven H; Kalincik T; Robertson N; Onofrj M; De Luca G; Di Tommaso V; Travaglini D; Pietrolongo E; di Ioia M; Farina D; Mancinelli L; Hodgkinson S; Oreja-Guevara C; Boz C; Prevost J; Olascoaga J; Van Wijmeersch B; Barnett M; Verheul F; Rojas JI; Spitaleri D; Rio ME; Taylor B; Luis Sanchez-Menoyo J; Ramo-Tello C; Solaro C; Csepany T; Iuliano G; Skibina O; Petersen T; Bolanos RF; Sidhom Y; Riadh ; Vucic S; Macdonell R; Sempere AP; Simo M; Kister I; Shuey N; Radek ; Dominguez JA; Pia Amato M; Saladino ML; Kermode A; Butler E; Moore F; Hughes S; McDonnell G; Piroska I; Yamout B; Soysal A; Ozakbas S; Zwanikken C, 2019, 'Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis', JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 321, pp. 175 - 187, http://dx.doi.org/10.1001/jama.2018.20588

Tea F; Lopez JA; Ramanathan S; Merheb V; Lee FXZ; Zou A; Pilli D; Patrick E; van der Walt A; Monif M; Tantsis EM; Yiu EM; Vucic S; Henderson APD; Fok A; Fraser CL; Lechner-Scott J; Reddel SW; Broadley S; Barnett MH; Brown DA; Lunemann JD; Dale RC; Brilot F; Sinclair A; Kermode AG; Kornberg A; Bye A; McGettigan B; Trewin B; Brew B; Taylor B; Bundell C; Miteff C; Troedson C; Pridmore C; Spooner C; Yiannikas C; O'Gorman C; Clark D; Suan D; Jones D; Kilfoyle D; Gill D; Wakefield D; Hofmann D; Mathey E; O'Grady G; Jones HF; Beadnall H; Butzkueven H; Joshi H; Andrews I; Sutton I; MacIntyre J; Sandbach JM; Freeman J; King J; O'Neill JH; Parratt J; Barton J; Garber J; Ahmad K; Riney K; Buzzard K; Kothur K; Cantrill LC; Menezes MP; Paine MA; Marriot M; Ghadiri M; Boggild M; Lawlor M; Badve M; Ryan M; Aaqib M; Shuey N; Jordan N; Urriola N; Lawn N; White O; McCombe P; Patel R; Leventer R; Webster R; Smith R; Gupta S; Mohammad SS; Pillai S; Hawke S; Simon S; Calvert S; Blum S; Malone S; Hodgkinson S; Nguyen TK; Hardy TA; Kalincik T; Ware T; Fung VSC, 2019, 'Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination', Acta Neuropathologica Communications, 7, http://dx.doi.org/10.1186/s40478-019-0786-3

Verma ND; Robinson CM; Carter N; Wilcox P; Tran GT; Wang C; Sharland A; Nomura M; Plain KM; Bishop GA; Hodgkinson SJ; Hall BM, 2019, 'Alloactivation of naïve CD4+ CD8− CD25+T regulatory cells: Expression of CD8α identifies potent suppressor cells that can promote transplant tolerance induction', Frontiers in Immunology, 10, pp. 2397, http://dx.doi.org/10.3389/fimmu.2019.02397

Desai M; Alsahli K; Cheung A; Wenderoth J; Kohli A; Cappelen-Smith C; Cordato D; Tay K; Hodgkinson S; McDougall A; Zagami AS; Manning NW, 2019, 'Abstract 154: Non-Contrast Computed Tomography Based Patient Selection Achieves Similar Outcomes to Advanced Neuroimaging in Late Time Window Endovascular Thrombectomy', Stroke, 50, http://dx.doi.org/10.1161/str.50.suppl_1.154

Hughes J; Jokubaitis V; Lugaresi A; Hupperts R; Izquierdo G; Prat A; Girard M; Duquette P; Grand'Maison F; Grammond P; Sola P; Ferraro D; Ramo-Tello C; Trojano M; Slee M; Shaygannejad V; Boz C; Lechner-Scott J; Van Pesch V; Pucci E; Solaro C; Verheul F; Terzi M; Granella F; Spitaleri D; Alroughani R; Jun JK; Fambiatos A; Van Der Walt A; Butzkueven H; Kalincik T, 2018, 'Association of Inflammation and Disability Accrual in Patients with Progressive-Onset Multiple Sclerosis', JAMA Neurology, 75, pp. 1407 - 1415, http://dx.doi.org/10.1001/jamaneurol.2018.2109

Kalincik T; Jokubaitis V; Spelman T; Horakova D; Havrdova E; Trojano M; Lechner-Scott J; Lugaresi A; Prat A; Girard M; Duquette P; Grammond P; Solaro C; Grand’Maison F; Hupperts R; Prevost J; Sola P; Ferraro D; Terzi M; Butler E; Slee M; Kermode A; Fabis-Pedrini M; McCombe P; Barnett M; Shaw C; Hodgkinson S; Butzkueven H, 2018, 'Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis', Multiple Sclerosis Journal, 24, pp. 1617 - 1626, http://dx.doi.org/10.1177/1352458517728812

de Stefano N; Achiron A; Barkhof F; Chan A; Derfuss T; Hodgkinson S; Leocani L; Montalban X; Prat A; Schmierer K; Sellebjerg F; Vermersch P; Wiendl H; Keller B; Roy S, 2018, 'THE MAGNIFY-MS STUDY: MAVENCLAD (R) TABLETS IN ACTIVE RMS', JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 89, http://dx.doi.org/10.1136/jnnp-2018-ABN.81

Kister I; Spelman T; Patti F; Duquette P; Trojano M; Izquierdo G; Lugaresi A; Grammond P; Sola P; Ferraro D; Grand'Maison F; Alroughani R; Terzi M; Boz C; Hupperts R; Lechner-Scott J; Kappos L; Pucci E; Hodgkinson S; Solaro C; Butzkueven H, 2018, 'Predictors of relapse and disability progression in MS patients who discontinue disease-modifying therapy', Journal of the Neurological Sciences, 391, pp. 72 - 76, http://dx.doi.org/10.1016/j.jns.2018.06.001

Kappos L; Bar-Or A; Cree BAC; Fox RJ; Giovannoni G; Gold R; Vermersch P; Arnold DL; Arnould S; Scherz T; Wolf C; Wallström E; Dahlke F; Achiron A; Achtnichts L; Agan K; Akman-Demir G; Allen AB; Antel JP; Antiguedad AR; Apperson M; Applebee AM; Ayuso GI; Baba M; Bajenaru O; Balasa R; Balci BP; Barnett M; Bass A; Becker VU; Bejinariu M; Bergh FT; Bergmann A; Bernitsas E; Berthele A; Bhan V; Bischof F; Bjork RJ; Blevins G; Boehringer M; Boerner T; Bonek R; Bowen JD; Bowling A; Boyko AN; Boz C; Bracknies V; Braune S; Brescia Morra V; Brochet B; Brola W; Brownstone PK; Brozman M; Brunet D; Buraga I; Burnett M; Buttmann M; Butzkueven H; Cahill J; Calkwood JC; Camu W; Cascione M; Castelnovo G; Centonze D; Cerqueira J; Chan A; Cimprichova A; Cohan S; Comi G; Conway J; Cooper JA; Corboy J; Correale J; Costell B; Cottrell DA; Coyle PK; Craner M; Cui L; Cunha L; Czlonkowska A; da Silva AM; de Sa J; de Seze J; Debouverie M; Debruyne J; Decoo D; Defer G; Derfuss T; Deri NH; Dihenia B; Dioszeghy P; Donath V; Dubois B; Duddy M; Duquette P; Edan G; Efendi H; Elias S; Emrich PJ; Estruch BC, 2018, 'Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study', Lancet, 391, pp. 1263 - 1273, http://dx.doi.org/10.1016/S0140-6736(18)30475-6

Venkat A; Cappelen-Smith C; Askar S; Thomas PR; Bhaskar S; Tam A; McDougall AJ; Hodgkinson SJ; Cordato DJ, 2018, 'Factors Associated with Stroke Misdiagnosis in the Emergency Department: A Retrospective Case-Control Study', Neuroendocrinology, 51, pp. 123 - 127, http://dx.doi.org/10.1159/000491635

Hardy TA; Young S; Sy JS; Colley AF; Terwindt GM; Ferrari MD; Hayes MW; Hodgkinson S, 2018, 'Tumefactive lesions in retinal vasculopathy with cerebral leucoencephalopathy and systemic manifestations (RVCLS): A role for neuroinflammation?', Journal of Neurology Neurosurgery and Psychiatry, 89, http://dx.doi.org/10.1136/jnnp-2017-316142

Tran GT; Wilcox PL; Dent LA; Robinson CM; Carter N; Verma ND; Hall BM; Hodgkinson SJ, 2017, 'Interleukin-5 Mediates Parasite-Induced Protection against Experimental Autoimmune Encephalomyelitis: Association with Induction of Antigen-Specific CD4+CD25+ T Regulatory Cells', Frontiers in Immunology, 8, pp. 1453, http://dx.doi.org/10.3389/fimmu.2017.01453

Kalincik T; Manouchehrinia A; Sobisek L; Jokubaitis V; Spelman T; Horakova D; Havrdova E; Trojano M; Izquierdo G; Lugaresi A; Girard M; Prat A; Duquette P; Grammond P; Sola P; Hupperts R; Grand'Maison F; Pucci E; Boz C; Alroughani R; Van Pesch V; Lechner-Scott J; Terzi M; Bergamaschi R; Iuliano G; Granella F; Spitaleri D; Shaygannejad V; Oreja-Guevara C; Slee M; Ampapa R; Verheul F; McCombe P; Olascoaga J; Amato MP; Vucic S; Hodgkinson S; Ramo-Tello C; Flechter S; Cristiano E; Rozsa C; Moore F; Sanchez-Menoyo JL; Saladino ML; Barnett M; Hillert J; Butzkueven H, 2017, 'Towards personalized therapy for multiple sclerosis: Prediction of individual treatment response', Brain, 140, pp. 2426 - 2443, http://dx.doi.org/10.1093/brain/awx185

Hall BM; Robinson CM; Plain KM; Verma ND; Tran GT; Nomura M; Carter N; Boyd R; Hodgkinson SJ, 2017, 'Changes in reactivity in vitro of CD4+ CD25+ and CD4+ CD25− T Cell subsets in transplant tolerance', Frontiers in Immunology, 8, pp. 994, http://dx.doi.org/10.3389/fimmu.2017.00994

Hall BM; Plain KM; Tran GT; Verma ND; Robinson CM; Nomura M; Boyd R; Hodgkinson SJ, 2017, 'Cytokines affecting CD4+ T regulatory cells in transplant tolerance. III. Interleukin-5 (IL-5) promotes survival of alloantigen-specific CD4+ T regulatory cells', Transplant Immunology, 43-44, pp. 33 - 41, http://dx.doi.org/10.1016/j.trim.2017.06.003

Bukhari W; Prain KM; Waters P; Woodhall M; O'Gorman CM; Clarke L; Silvestrini RA; Bundell CS; Abernethy D; Bhuta S; Blum S; Boggild M; Boundy K; Brew BJ; Brown M; Brownlee WJ; Butzkueven H; Carroll WM; Chen C; Coulthard A; Dale RC; Das C; Dear K; Fabis-Pedrini MJ; Fulcher D; Gillis D; Hawke S; Heard R; Henderson APD; Heshmat S; Hodgkinson S; Jimenez-Sanchez S; Killpatrick T; King J; Kneebone C; Kornberg AJ; Lechner-Scott J; Lin MW; Lynch C; Macdonell R; Mason DF; McCombe PA; Pender MP; Pereira JA; Pollard JD; Reddel SW; Shaw C; Spies J; Stankovich J; Sutton I; Vucic S; Walsh M; Wong RC; Yiu EM; Barnett MH; Kermode AG; Marriott MP; Parratt JDE; Slee M; Taylor BV; Willoughby E; Wilson RJ; Vincent A; Broadley SA, 2017, 'Incidence and prevalence of NMOSD in Australia and New Zealand', Journal of Neurology Neurosurgery and Psychiatry, 88, pp. 632 - 638, http://dx.doi.org/10.1136/jnnp-2016-314839

Gonsalvez DG; Tran G; Fletcher JL; Hughes RA; Hodgkinson S; Wood RJ; Yoo SW; De Silva M; Agnes WW; McLean C; Kennedy P; Kilpatrick TJ; Murray SS; Xiao J, 2017, 'A brain-derived neurotrophic factor-based p75NTR peptide mimetic ameliorates experimental autoimmune neuritis induced axonal pathology and demyelination', Eneuro, 4, http://dx.doi.org/10.1523/ENEURO.0142-17.2017

Nomura M; Hodgkinson SJ; Tran GT; Verma ND; Robinson C; Plain KM; Boyd R; Hall BM, 2017, 'Cytokines affecting CD4+ T regulatory cells in transplant tolerance. II. Interferon gamma (IFN-γ) promotes survival of alloantigen-specific CD4+ T regulatory cells', Transplant Immunology, 42, pp. 24 - 33, http://dx.doi.org/10.1016/j.trim.2017.05.002

Back to profile page